Tokyo, Oct. 1 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000059242) titled 'Investigating changes in bone marrow using photon-counting computed tomography' on Oct. 1.
Study Type:
Observational
Primary Sponsor:
Institute - Central Hospital of Matto Ishikawa
Condition:
Condition - Head and neck cancer
Classification by malignancy - Malignancy
Genomic information - NO
Objective:
Narrative objectives1 - Hematologic toxicities can be dose-limiting effects in radiotherapy, but the degree of radiotherapy effects on the toxicities have not been elucidated in chemoradiation.This study aims to understand radiotherapy effects on changes in red-bone marrow using NAEOTOM Alpha (photon-counting CT)
Basic objectives2 - Others
Eligibility:
Age-lower limit - 20
years-old
<=
Age-upper limit - Not applicable
Gender - Male and Female
Key inclusion criteria - Patients who undergo radiotherapy for head and neck cancer at our facility (Public Central Hospital of Matto Ishikawa).
Key exclusion criteria - Patients who are claustrophobic, pregnant or lactating.
Patients who refuse to participate this trial.
We make sure that the burdens and the risks are well explained to the patients.
Target Size - 35
Recruitment Status:
Recruitment status - Preinitiation
Date of protocol fixation - 2025 Year 09 Month 25 Day
Date of IRB - 2025 Year 09 Month 26 Day
Anticipated trial start date - 2025 Year 10 Month 01 Day
Last follow-up date - 2028 Year 09 Month 30 Day
To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000066795
Disclaimer: Curated by HT Syndication.
